Weiyu Shen

机构：Ningbo Medical Center Lihuili Hospital · ORCID：0009-0007-3870-6534

发表论文 84 篇 · 总被引 1970 次 · h-index 21

代表论文

• Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy (2023 · Immunological Reviews · 被引 115)
• Exosome-mediated metabolic reprogramming: Implications in esophageal carcinoma progression and tumor microenvironment remodeling (2023 · Cytokine & Growth Factor Reviews · 被引 31)
• Evaluating the predictive significance of systemic immune-inflammatory index and tumor markers in lung cancer patients with bone metastases (2024 · Frontiers in Oncology · 被引 10)
• CD146 deficiency aggravates chronic obstructive pulmonary disease via the increased production of S100A9 and MMP-9 in macrophages (2023 · International Immunopharmacology · 被引 9)
• Targeted-lung delivery of bardoxolone methyl using PECAM-1 antibody-conjugated nanostructure lipid carriers for the treatment of lung inflammation (2024 · Biomedicine & Pharmacotherapy · 被引 7)
• Two versus three to four cycles of neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma in real-world practice (2024 · Journal of Thoracic Disease · 被引 6)